Healthcare

Homegrown medtech firm taps unique technology to capture multi-billion dollar bone regenerating market

SINGAPORE (June 10): Singapore’s medical trend rate of 10% outpaced economic inflation 10-fold in 2018, and is expected to rise by 0.1% in 2019, according to Mercer Marsh Benefits (MMB) 2019 Trends Around the World report.

SINGAPORE (June 10): UOB Venture Management (UOBVM) says it intends to roll out its second impact fund, the second series of the Asia Impact Investment Fund (AIIF II), to global institutional and accredited investors in 2H19.

SINGAPORE (June 6): Acromec has entered into a letter of intent (LOI) to collaborate on owning and operating a private fertility centre backed by a “leading US fertility centre” as a strategic investor and advisor.  

SINGAPORE (June 4): Integrated healthcare company Clearbridge Health says it is planning to open a new 1,500 sq ft clinic along Causeway Bay, Hong Kong, to serve more domestic patients and medical tourists.

SINGAPORE (May 31): UOB Kay Hian is maintaining “buy” on IHH Healthcare with a target price of RM6.30 ($2.07), which implies 32.8 times 2020F P/E – well below its historical five-year 12 month forward P/E of 57 times based on the stock’s performan

SINGAPORE (May 13): Thomson Medical Group (TMG), formerly known as Rowsley, has announced a $1 million loss for the 1Q ended March, reversing from earnings of $89,000 in 1Q18 due to a spike in finance costs in the recent quarter under review.

SINGAPORE (May 9): Singapore O&G (SOG) has reported earnings of $2.1 million for 1Q19, down 15.5% from $2.5 million a year ago due to higher operational expenses.

SINGAPORE (May 8): OUE Lippo Healthcare (OUE LH) has posted $0.2 million earnings, reversing from its 1Q18 loss of $2.7 million due to lower finance costs, higher other income as well as higher share of results of equity-accounted investees.